middle.news

BCAL Diagnostics Boosts Cancer Test Reach and Secures Strategic Funding

8:38am on Thursday 30th of July, 2026 AEST Healthcare
Read Story

BCAL Diagnostics Boosts Cancer Test Reach and Secures Strategic Funding

8:38am on Thursday 30th of July, 2026 AEST
Key Points
  • New CEO Anne-Louise Arnett appointed with 25+ years experience
  • BREASTEST Monitor shows promising initial clinical sensitivity
  • Validation deal signed with Sonic Healthcare USA for BREASTESTplus V2
  • EarlyDetection.com.au platform expands national referral access
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Bcal Diagnostics (ASX:BDX)
OPEN ARTICLE